546 related articles for article (PubMed ID: 25151951)
1. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Felizola SJ; Maekawa T; Nakamura Y; Satoh F; Ono Y; Kikuchi K; Aritomi S; Ikeda K; Yoshimura M; Tojo K; Sasano H
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():410-6. PubMed ID: 25151951
[TBL] [Abstract][Full Text] [Related]
2. Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.
Felizola SJ; Katsu K; Ise K; Nakamura Y; Arai Y; Satoh F; Sasano H
Endocr Pathol; 2015 May; 26(2):119-28. PubMed ID: 25861052
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
4. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
5. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
[TBL] [Abstract][Full Text] [Related]
7. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
8. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
9. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
10. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Scholl UI; Lifton RP
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
[TBL] [Abstract][Full Text] [Related]
11. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
[TBL] [Abstract][Full Text] [Related]
12. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
[TBL] [Abstract][Full Text] [Related]
13. Different cell compositions and a novel somatic
Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.
Fallo F; Pezzi V; Barzon L; Mulatero P; Veglio F; Sonino N; Mathis JM
Eur J Endocrinol; 2002 Dec; 147(6):795-802. PubMed ID: 12457455
[TBL] [Abstract][Full Text] [Related]
15. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
16. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
[TBL] [Abstract][Full Text] [Related]
17. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
18. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R
Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
